Liquidata Share/ETF/Trust Analysis
Portfolio Holdings Detail for ISIN IE00BF4RFH31
| Stock Name / Fund | iShares MSCI World Small Cap UCITS ETF USD (Acc) |
| Issuer | Blackrock |
| Entity holding fund | iShares III Public Limited Company |
| Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
| Entity LEI | 549300PZLRJB7M8H1057 |
| ETF Ticker | WSML(USD) LSE |
| ETF Ticker | WLDS(GBP) LSE |
| ETF Ticker | IUSN(EUR) F |
| ETF Ticker | IUSN.DE(EUR) CXE |
| ETF Ticker | WLDS.LS(GBP) CXE |
| ETF Ticker | WSML.LS(USD) CXE |
| ETF Ticker | WSML.L(GBP) LSE |
| ETF Ticker | WLDS.L(GBP) LSE |
Holdings detail for LAB
| Stock Name | Standard Biotools Inc |
| Ticker | LAB(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US34385P1084 |
| LEI | 549300GX8Y96GSB6YP89 |
Show aggregate LAB holdings
News associated with LAB
- Critical Survey: Standard BioTools (NASDAQ:LAB) & P3 Health Partners (NASDAQ:PIII)
- Standard BioTools (NASDAQ:LAB – Get Free Report) and P3 Health Partners (NASDAQ:PIII – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, profitability, earnings, institutional ownership and dividends. Volatility and Risk Standard BioTools has […] - 2025-08-18 05:46:52
- Standard BioTools (NASDAQ:LAB) Raised to “Hold” at Wall Street Zen
- Standard BioTools (NASDAQ:LAB – Get Free Report) was upgraded by analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research note issued to investors on Saturday. LAB has been the topic of a number of other reports. Cowen cut shares of Standard BioTools from a “buy” rating to a […] - 2025-08-18 04:46:56
- XTX Topco Ltd Purchases New Holdings in Standard BioTools Inc. (NASDAQ:LAB)
- XTX Topco Ltd purchased a new stake in shares of Standard BioTools Inc. (NASDAQ:LAB – Free Report) in the first quarter, Holdings Channel reports. The firm purchased 158,087 shares of the company’s stock, valued at approximately $171,000. A number of other institutional investors and hedge funds also recently modified their holdings of the business. Oppenheimer […] - 2025-08-14 04:25:02
- Standard BioTools Inc. (NASDAQ:LAB) Stock Holdings Decreased by Sumitomo Mitsui Trust Group Inc.
- Sumitomo Mitsui Trust Group Inc. lessened its holdings in shares of Standard BioTools Inc. (NASDAQ:LAB – Free Report) by 5.8% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 6,233,693 shares of the company’s stock after selling 384,701 shares during the period. […] - 2025-07-04 05:10:58
- California State Teachers Retirement System Sells 18,285 Shares of Standard BioTools Inc. (NASDAQ:LAB)
- California State Teachers Retirement System decreased its holdings in Standard BioTools Inc. (NASDAQ:LAB – Free Report) by 7.9% in the 4th quarter, HoldingsChannel reports. The firm owned 213,266 shares of the company’s stock after selling 18,285 shares during the quarter. California State Teachers Retirement System’s holdings in Standard BioTools were worth $373,000 at the end […] - 2025-06-12 04:52:48
- Wells Fargo & Company MN Acquires 40,894 Shares of Standard BioTools Inc. (NASDAQ:LAB)
- Wells Fargo & Company MN lifted its stake in shares of Standard BioTools Inc. (NASDAQ:LAB – Free Report) by 29.1% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 181,256 shares of the company’s stock after buying an additional 40,894 shares during […] - 2025-05-06 04:18:54
- Invesco Ltd. Grows Position in Standard BioTools Inc. (NASDAQ:LAB)
- Invesco Ltd. boosted its position in shares of Standard BioTools Inc. (NASDAQ:LAB – Free Report) by 7.5% during the 4th quarter, HoldingsChannel.com reports. The firm owned 175,041 shares of the company’s stock after acquiring an additional 12,194 shares during the quarter. Invesco Ltd.’s holdings in Standard BioTools were worth $306,000 at the end of the […] - 2025-05-05 04:38:52
- Rockefeller Capital Management L.P. Grows Stock Holdings in Standard BioTools Inc. (NASDAQ:LAB)
- Rockefeller Capital Management L.P. grew its holdings in Standard BioTools Inc. (NASDAQ:LAB – Free Report) by 83.6% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 296,631 shares of the company’s stock after acquiring an additional 135,075 shares during the period. Rockefeller […] - 2025-04-24 05:56:54
- Commonwealth Equity Services LLC Sells 51,993 Shares of Standard BioTools Inc. (NASDAQ:LAB)
- Commonwealth Equity Services LLC lowered its stake in Standard BioTools Inc. (NASDAQ:LAB – Free Report) by 31.5% during the fourth quarter, Holdings Channel.com reports. The fund owned 113,000 shares of the company’s stock after selling 51,993 shares during the period. Commonwealth Equity Services LLC’s holdings in Standard BioTools were worth $198,000 as of its most […] - 2025-04-11 04:30:44
- Cibc World Markets Corp Invests $48,000 in Standard BioTools Inc. (NASDAQ:LAB)
- Cibc World Markets Corp purchased a new stake in shares of Standard BioTools Inc. (NASDAQ:LAB – Free Report) in the 4th quarter, HoldingsChannel.com reports. The firm purchased 27,606 shares of the company’s stock, valued at approximately $48,000. A number of other large investors have also added to or reduced their stakes in LAB. Hollow Brook […] - 2025-03-28 06:18:48
- Standard BioTools Inc. (NASDAQ:LAB) Shares Sold by Sumitomo Mitsui Trust Group Inc.
- Sumitomo Mitsui Trust Group Inc. lowered its stake in Standard BioTools Inc. (NASDAQ:LAB – Free Report) by 30.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 6,618,394 shares of the company’s stock after selling 2,960,169 shares during the period. Sumitomo Mitsui […] - 2025-02-13 07:28:55
iShares MSCI World Small Cap UCITS ETF USD (Acc) LAB holdings
| Date | Number of LAB Shares Held | Base Market Value of LAB Shares | Local Market Value of LAB Shares | Change in LAB Shares Held | Change in LAB Base Value | Current Price per LAB Share Held | Previous Price per LAB Share Held |
|---|
| 2025-10-15 (Wednesday) | 132,967 | USD 186,154 | USD 186,154 | | | | |
| 2025-10-10 (Friday) | 132,019 | USD 168,984 | USD 168,984 | | | | |
| 2025-10-08 (Wednesday) | 132,019 | USD 174,265 | USD 174,265 | | | | |
| 2025-10-07 (Tuesday) | 132,019 | USD 171,625 | USD 171,625 | 630 | USD -1,808 | USD 1.3 | USD 1.32 |
| 2025-10-06 (Monday) | 131,389 | USD 173,433 | USD 173,433 | 0 | USD -2,628 | USD 1.32 | USD 1.34 |
| 2025-10-03 (Friday) | 131,389 | USD 176,061 | USD 176,061 | 0 | USD 7,883 | USD 1.34 | USD 1.28 |
| 2025-10-02 (Thursday) | 131,389 | USD 168,178 | USD 168,178 | 0 | USD 0 | USD 1.28 | USD 1.28 |
| 2025-10-01 (Wednesday) | 131,389 | USD 168,178 | USD 168,178 | 0 | USD -2,628 | USD 1.28 | USD 1.3 |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of LAB by Blackrock for IE00BF4RFH31
Show aggregate share trades of LAB| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-10-07 | BUY | 630 | | | 1.300* | | 1.39 |
| 2025-09-08 | SELL | -1,260 | | | 1.360* | | 1.39 Profit of 1,758 on sale |
| 2025-08-15 | BUY | 628 | | | 1.230* | | 1.40 |
| 2025-07-14 | BUY | 1,248 | | | 1.250* | | 1.40 |
| 2025-06-30 | BUY | 1,248 | | | 1.200* | | 1.40 |
| 2025-06-25 | BUY | 1,860 | | | 1.250* | | 1.40 |
| 2025-06-20 | SELL | -310 | | | 1.050* | | 1.41 Profit of 437 on sale |
| 2025-06-12 | SELL | -2,496 | | | 1.050* | | 1.42 Profit of 3,553 on sale |
| 2025-06-02 | BUY | 936 | | | 1.050* | | 1.44 |
| 2025-05-28 | BUY | 624 | | | 1.090* | | 1.45 |
| 2025-05-14 | BUY | 310 | | | 1.070* | | 1.49 |
| 2025-05-13 | BUY | 620 | | | 1.140* | | 1.49 |
| 2025-05-07 | BUY | 930 | | | 1.020* | | 1.50 |
| 2025-04-28 | BUY | 310 | | | 1.180* | | 1.53 |
| 2025-04-16 | BUY | 4,004 | | | 1.130* | | 1.55 |
| 2025-04-14 | BUY | 616 | | | 1.150* | | 1.56 |
| 2025-04-08 | SELL | -616 | | | 1.030* | | 1.58 Profit of 971 on sale |
| 2025-04-04 | SELL | -618 | | | 1.070* | | 1.59 Profit of 981 on sale |
| 2025-03-28 | BUY | 3,070 | | | 1.140* | | 1.61 |
| 2025-03-12 | SELL | -616 | | | 1.150* | | 1.67 Profit of 1,030 on sale |
| 2025-03-04 | SELL | -616 | | | 1.060* | | 1.71 Profit of 1,052 on sale |
| 2025-02-26 | SELL | -1,232 | | | 1.170* | | 1.74 Profit of 2,146 on sale |
| 2025-02-13 | BUY | 308 | | | 1.330* | | 1.80 |
| 2025-02-12 | BUY | 1,232 | | | 1.355* | | 1.80 |
| 2025-01-27 | BUY | 308 | | | 1.570* | | 1.88 |
| 2025-01-23 | BUY | 308 | | | 1.655* | | 1.89 |
| 2024-12-09 | BUY | 10,908 | | | 1.930* | | 1.89 |
| 2024-12-04 | BUY | 606 | | | 1.850* | | 1.89 |
| 2024-12-03 | BUY | 906 | | | 1.830* | | 1.89 |
| 2024-11-19 | BUY | 1,806 | | | 1.510* | | 1.95 |
| 2024-11-18 | BUY | 602 | | | 1.500* | | 1.97 |
| 2024-11-12 | BUY | 1,204 | | | 2.050* | | 1.97 |
| 2024-11-11 | BUY | 301 | | | 2.230* | | 1.95 |
| 2024-11-11 | BUY | 301 | | | 2.230* | | 1.95 |
| 2024-11-07 | BUY | 1,500 | | | 2.180* | | 1.91 |
| 2024-11-07 | BUY | 1,500 | | | 2.180* | | 1.91 |
| 2024-10-23 | BUY | 600 | | | 1.780* | | 1.86 |
| 2024-10-23 | BUY | 600 | | | 1.780* | | 1.86 |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of LAB
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-09-19 | 251,590 | 0 | 706,480 | 35.6% |
| 2025-09-18 | 117,423 | 600 | 293,654 | 40.0% |
| 2025-09-17 | 151,147 | 0 | 287,054 | 52.7% |
| 2025-09-16 | 107,432 | 0 | 322,075 | 33.4% |
| 2025-09-15 | 413,297 | 0 | 717,604 | 57.6% |
| 2025-09-12 | 99,182 | 0 | 364,751 | 27.2% |
| 2025-09-11 | 120,539 | 2,018 | 299,466 | 40.3% |
| 2025-09-10 | 244,794 | 0 | 287,793 | 85.1% |
| 2025-09-09 | 173,691 | 25 | 303,055 | 57.3% |
| 2025-09-08 | 383,254 | 12,218 | 1,227,937 | 31.2% |
| 2025-09-05 | 151,119 | 5 | 598,429 | 25.3% |
| 2025-09-04 | 160,556 | 0 | 373,750 | 43.0% |
| 2025-09-03 | 229,192 | 10 | 490,353 | 46.7% |
| 2025-09-02 | 137,466 | 0 | 306,092 | 44.9% |
| 2025-08-29 | 85,237 | 0 | 221,446 | 38.5% |
| 2025-08-28 | 99,223 | 0 | 272,983 | 36.3% |
| 2025-08-27 | 222,747 | 800 | 687,539 | 32.4% |
| 2025-08-26 | 87,989 | 0 | 299,844 | 29.3% |
| 2025-08-25 | 112,752 | 950 | 448,715 | 25.1% |
| 2025-08-22 | 120,216 | 49 | 723,244 | 16.6% |
| 2025-08-21 | 79,652 | 0 | 328,528 | 24.2% |
| 2025-08-20 | 90,910 | 0 | 483,661 | 18.8% |
| 2025-08-19 | 97,102 | 93 | 257,041 | 37.8% |
| 2025-08-18 | 231,447 | 4,600 | 615,351 | 37.6% |
| 2025-08-15 | 125,473 | 44,078 | 351,846 | 35.7% |
| 2025-08-14 | 293,568 | 17,229 | 803,839 | 36.5% |
| 2025-08-13 | 360,867 | 1,495 | 732,304 | 49.3% |
| 2025-08-12 | 151,678 | 0 | 362,316 | 41.9% |
| 2025-08-11 | 337,166 | 0 | 514,679 | 65.5% |
| 2025-08-08 | 146,108 | 22 | 844,000 | 17.3% |
| 2025-08-07 | 107,039 | 0 | 192,759 | 55.5% |
| 2025-08-06 | 90,951 | 0 | 172,962 | 52.6% |
| 2025-08-05 | 52,298 | 0 | 82,874 | 63.1% |
| 2025-08-04 | 103,873 | 0 | 781,660 | 13.3% |
| 2025-08-01 | 241,792 | 2,209 | 445,368 | 54.3% |
| 2025-07-31 | 216,703 | 0 | 465,134 | 46.6% |
| 2025-07-30 | 276,859 | 0 | 464,405 | 59.6% |
| 2025-07-29 | 204,216 | 0 | 368,998 | 55.3% |
| 2025-07-28 | 118,586 | 213 | 313,251 | 37.9% |
| 2025-07-25 | 128,821 | 0 | 537,182 | 24.0% |
| 2025-07-24 | 282,018 | 0 | 621,257 | 45.4% |
| 2025-07-23 | 389,626 | 2,200 | 1,315,860 | 29.6% |
| 2025-07-22 | 220,080 | 727 | 756,231 | 29.1% |
| 2025-07-21 | 371,863 | 0 | 536,251 | 69.3% |
| 2025-07-18 | 444,297 | 0 | 636,280 | 69.8% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Disclaimer
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.